429 filings
Page 21 of 22
PRE 14A
ga2irmtx1n3
17 Oct 14
Preliminary proxy
12:00am
8-K
7nxex6upa7s5ll4n1b
15 Oct 14
ContraVir Pharmaceuticals Closes $9.0 Million Financing to Advance Lead Shingles Candidate
12:00am
10-K
5new5fcj
29 Sep 14
Annual report
12:00am
RW
032y4ywrykxsa
26 Sep 14
Registration withdrawal request
12:00am
8-K
xir0df0h
22 Aug 14
Unregistered Sales of Equity Securities
12:00am
D
oogicrhi
22 Aug 14
$4.74M in equity, sold $4.74M, 19 investors
12:00am
8-K
zq8yuwkxq3j07r1rh
26 Jun 14
Departure of Directors or Certain Officers
12:00am
S-1/A
7e23f vqxb8f9gp
2 Jun 14
IPO registration (amended)
12:00am
S-1
59xqcd95
12 May 14
IPO registration
12:00am
8-K
pur4dbp9d67nvadz
20 Mar 14
ContraVir Appoints James Sapirstein as Chief Executive Officer and Board Member
12:00am
D
g6lptrh
14 Feb 14
$3.23M in equity / options, sold $3.23M, 19 investors
12:00am
10-12G/A
lic oqbroy0o
6 Feb 14
Registration of securities (amended)
12:00am
8-K
hu9id0
5 Feb 14
Entry into a Material Definitive Agreement
12:00am
UPLOAD
9rf39u wfiev2
3 Feb 14
Letter from SEC
12:00am
CT ORDER
a5reg7nu
3 Feb 14
Confidential treatment order
12:00am
10-12G/A
ct9qvzfv863id1w
24 Dec 13
Registration of securities (amended)
12:00am
UPLOAD
8c6027f53c3h9 jjo0ze
11 Dec 13
Letter from SEC
12:00am
8-K
x92qb
27 Nov 13
Departure of Directors or Certain Officers
12:00am